Tumor targeted 4-1BB agonist antibody-albumin fusions with high affinity to FcRn induce anti-tumor immunity without toxicity

  1. Hangiu, O.
  2. Compte, M.
  3. Dinesen, A.
  4. Navarro, R.
  5. Tapia-Galisteo, A.
  6. Mandrup, O.A.
  7. Erce-Llamazares, A.
  8. Lázaro-Gorines, R.
  9. Nehme-Álvarez, D.
  10. Domínguez-Alonso, C.
  11. Harwood, S.L.
  12. Alfonso, C.
  13. Blanco, B.
  14. Rubio-Pérez, L.
  15. Jiménez-Reinoso, A.
  16. Díez-Alonso, L.
  17. Blanco, F.J.
  18. Sanz, L.
  19. Howard, K.A.
  20. Álvarez-Vallina, L.
Aldizkaria:
iScience

ISSN: 2589-0042

Argitalpen urtea: 2022

Alea: 25

Zenbakia: 9

Mota: Artikulua

DOI: 10.1016/J.ISCI.2022.104958 GOOGLE SCHOLAR lock_openSarbide irekia editor

Garapen Iraunkorreko Helburuak

Datuen iturria: Scopus